Semma Therapeutics Overview
- Founded
-
2014

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$937M
Semma Therapeutics General Information
Description
Developer of trans-formative therapies designed to eliminate the use of insulin injections for type 1 diabetes patients. The company's trans-formative therapies is a cell-based therapy for diabetes which traditionally requires the use of an invasive insulin pump or multiple daily insulin injections combining proprietary cells with a state-of-the-art device to provide a replacement for the missing beta cells in a diabetic patient without immunosuppression, enabling doctors to provide a functional cure for patients with diabetes.
Contact Information
Primary Office
- 100 Technology Square
- Floor 3
- Cambridge, MA 02139
- United States
Semma Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 10-Oct-2019 | $937M | 00000 | 00000 | Completed | Generating Revenue |
3. Early Stage VC (Series B) | 30-Nov-2017 | 00000 | 00000 | Completed | Startup | |
2. Grant | 12-Sep-2016 | $5M | $44M | Completed | Startup | |
1. Early Stage VC (Series A) | 24-Mar-2015 | $44M | $44M | 000.00 | Completed | Startup |
Semma Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Semma Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of trans-formative therapies designed to eliminate the use of insulin injections for type 1 diabetes patients.
Drug Discovery
Cambridge, MA
00000
0000
0000-00-00
000000&0
00000
Semma Therapeutics Competitors (51)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Calimmune | Formerly VC-backed | Tucson, AZ | 00 | 000.00 | 000000&0 | 000.00 |
0000000 | Corporation | London, Canada | 00 | 000.00 | 00000000 | 000.00 |
000000 | Venture Capital-Backed | Ann Arbor, MI | 00 | 00000 | 000000 - 000 | 00000 |
0000000 | Formerly VC-backed | Boston, MA | 000 | 00000 | 000000000 | 00000 |
00000000 | Formerly VC-backed | South San Francisco, CA | 00 | 00000 | 000000000 | 00000 |
Semma Therapeutics Former Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
6 Dimensions Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
ARCH Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
California Institute for Regenerative Medicine | Government | 000 0000 | 000000 0 | ||
Cowen Healthcare Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
Eight Roads | Venture Capital | Minority | 000 0000 | 000000 0 |
Semma Therapeutics Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 | 16-Nov-2015 | 0000000000 | Biotechnology | 0000000 0 |